These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15031796)

  • 21. Effect of LACK and KMP11 on IFN-gamma production by peripheral blood mononuclear cells from cutaneous and mucosal leishmaniasis patients.
    Carvalho LP; Passos S; Dutra WO; Soto M; Alonso C; Gollob KJ; Carvalho EM; Ribeiro de Jesus A
    Scand J Immunol; 2005 Apr; 61(4):337-42. PubMed ID: 15853916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphisms of cytochrome b gene in Leishmania parasites and their relation to types of cutaneous leishmaniasis lesions in Pakistan.
    Myint CK; Asato Y; Yamamoto Y; Kato H; Bhutto AM; Soomro FR; Memon MZ; Matsumoto J; Marco JD; Oshiro M; Katakura K; Hashiguchi Y; Uezato H
    J Dermatol; 2008 Feb; 35(2):76-85. PubMed ID: 18271802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?
    Gomes-Silva A; de Cássia Bittar R; Dos Santos Nogueira R; Amato VS; da Silva Mattos M; Oliveira-Neto MP; Coutinho SG; Da-Cruz AM
    Clin Exp Immunol; 2007 Sep; 149(3):440-4. PubMed ID: 17614975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients.
    Rafati S; Gholami E; Hassani N; Ghaemimanesh F; Taslimi Y; Taheri T; Soong L
    Vaccine; 2007 May; 25(21):4159-69. PubMed ID: 17395340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in phenotypic profiles of peripheral blood cells from patients with human American cutaneous leishmaniasis following treatment with an antimonial drug and a vaccine.
    Botelho AC; Mayrink W; Oliveira RC
    Acta Trop; 2009 Nov; 112(2):143-8. PubMed ID: 19631187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER: an Iranian strain of cutaneous leishmaniasis.
    Nahrevanian H; Farahmand M; Aghighi Z; Assmar M; Amirkhani A
    Exp Parasitol; 2007 Jul; 116(3):233-40. PubMed ID: 17335813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin 4 (IL-4) gene promoter polymorphisms in Rhombomys opimus, the main reservoir of zoonotic cutaneous leishmaniasis.
    Bakhshi H; Borhani N; Mohebali M; Khamesipour A; Abai MR; Hajjaran H; Tajedin L; Rassi Y; Akhavan AA; Mohtarami F; Oshaghi MA
    Cytokine; 2014 Jan; 65(1):1-3. PubMed ID: 24209596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and histopathological features of zoonotic cutaneous leishmaniasis in Saudi Arabia.
    Uthman MA; Satir AA; Tabbara KS
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):431-6. PubMed ID: 15987288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of antibodies and cell mediated immune response against Leishmania major in feral nonhuman primates from Kenya.
    Gicheru MM; Jeneby MM; Macharia JC; Carlsson HE; Suleman MA
    Acta Trop; 2009 Feb; 109(2):136-40. PubMed ID: 18983806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells.
    Bertholet S; Debrabant A; Afrin F; Caler E; Mendez S; Tabbara KS; Belkaid Y; Sacks DL
    Infect Immun; 2005 Oct; 73(10):6620-8. PubMed ID: 16177338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serial study of the immune response of an individual with exacerbated simple cutaneous leishmaniasis.
    Klaus SN; Frankenburg S; Gross A; Jonas F; Vardy D
    Isr J Med Sci; 1994 Jan; 30(1):19-21. PubMed ID: 8138392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.
    Romero GA; de la Glória Orge Orge M; de Farias Guerra MV; Paes MG; de Oliveira Macêdo V; de Carvalho EM
    Acta Trop; 2005 Jan; 93(1):49-56. PubMed ID: 15589797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surrogate markers of immunity to Leishmania major in leishmanin skin test negative individuals from an endemic area re-visited.
    Nylén S; Khamesipour A; Mohammadi A; Jafari-Shakib R; Eidsmo L; Noazin S; Modabber F; Akuffo H
    Vaccine; 2006 Nov; 24(47-48):6944-54. PubMed ID: 17049693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
    Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
    Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.
    Iborra S; Soto M; Carrión J; Alonso C; Requena JM
    Vaccine; 2004 Sep; 22(29-30):3865-76. PubMed ID: 15364433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of mannose receptor during experimental leishmaniasis.
    Akilov OE; Kasuboski RE; Carter CR; McDowell MA
    J Leukoc Biol; 2007 May; 81(5):1188-96. PubMed ID: 17261547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection of C3HeB/FeJ mice against Leishmania amazonensis challenge after previous Leishmania major infection.
    Vanloubbeeck Y; Jones DE
    Am J Trop Med Hyg; 2004 Oct; 71(4):407-11. PubMed ID: 15516635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis.
    Liese J; Schleicher U; Bogdan C
    Eur J Immunol; 2007 Dec; 37(12):3424-34. PubMed ID: 18034422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.